Show simple item record

dc.contributor.authorMedina, Narda
dc.contributor.authorSoto-Debrán, Juan Carlos
dc.contributor.authorSeidel, Danila
dc.contributor.authorAkyar, Isin
dc.contributor.authorBadali, Hamid
dc.contributor.authorBarac, Aleksandra
dc.contributor.authorBretagne, Stéphane
dc.contributor.authorCag, Yasemin
dc.contributor.authorCassagne, Carole
dc.contributor.authorCastro González, Carmen 
dc.contributor.authorChakrabarti, Arunaloke
dc.contributor.authorDannaoui, Eric
dc.contributor.authorCardozo, Celia
dc.contributor.authorGarcia Rodriguez, Julio
dc.contributor.authorGuitard, Juliette
dc.contributor.authorHamal, Petr
dc.contributor.authorHoenigl, Martin
dc.contributor.authorJagielski, Tomasz
dc.contributor.authorKhodavaisy, Sadegh
dc.contributor.authorLo Cascio, Giuliana
dc.contributor.authorMartínez Rubio, María Carmen 
dc.contributor.authorMeletiadis, Joseph
dc.contributor.authorMuñoz, Patricia
dc.contributor.authorOchman, Elzbieta
dc.contributor.authorPeláez, Teresa
dc.contributor.authorPerez-Ayala Balzola, Ana
dc.contributor.authorPrattes, Juergen
dc.contributor.authorRoilides, Emmanuel
dc.contributor.authorRuíz-Pérez de Pipaón, Maite
dc.contributor.authorStauf, Raphael
dc.contributor.authorSteinmann, Jörg
dc.contributor.authorSuárez-Barrenechea, Ana Isabel
dc.contributor.authorTejero, Rocío
dc.contributor.authorTrovato, Laura
dc.contributor.authorViñuela, Lourdes
dc.contributor.authorWongsuk, Thanwa
dc.contributor.authorZak, Iwona
dc.contributor.authorZarrinfar, Hossein
dc.contributor.authorLass-Flörl, Cornelia
dc.contributor.authorArikan-Akdagli, Sevtap
dc.contributor.authorAlastruey-Izquierdo, Ana
dc.contributor.authorMixInYeast Study Group from EFISG
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2021-02-23T08:53:37Z
dc.date.available2021-02-23T08:53:37Z
dc.date.issued2021-01
dc.identifier.issn2309-608X
dc.identifier.urihttp://hdl.handle.net/10498/24543
dc.description.abstractInvasive candidiasis remains one of the most prevalent systemic mycoses, and several studies have documented the presence of mixed yeast (MY) infections. Here, we describe the epidemiology, clinical, and microbiological characteristics of MY infections causing invasive candidiasis in a multicenter prospective study. Thirty-four centers from 14 countries participated. Samples were collected in each center between April to September 2018, and they were sent to a reference center to confirm identification by sequencing methods and to perform antifungal susceptibility testing, according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). A total of 6895 yeast cultures were identified and MY occurred in 150 cases (2.2%). Europe accounted for the highest number of centers, with an overall MY rate of 4.2% (118 out of 2840 yeast cultures). Of 122 MY cases, the most frequent combinations were Candida albicans/C. glabrata (42, 34.4%), C. albicans/C. parapsilosis (17, 14%), and C. glabrata/C. tropicalis (8, 6.5%). All Candida isolates were susceptible to amphotericin B, 6.4% were fluconazole-resistant, and two isolates (1.6%) were echinocandin-resistant. Accurate identification of the species involved in MY infections is essential to guide treatment decisions.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJ. Fungi 2021, 7(1), 13es_ES
dc.subjectyeastes_ES
dc.subjectchrome agares_ES
dc.subjectinvasive candidiasises_ES
dc.subjectCandidaes_ES
dc.subjectmix infectionses_ES
dc.subjectpolymicrobial infectionses_ES
dc.titleMixInYeast: A Multicenter Study on Mixed Yeast Infectionses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/jof7010013


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional